Home » Topics » BioWorld

BioWorld
RSS

ONCOR RAISES $31.5 MILLION IN SECONDARY

Jan. 30, 1992

PDL IPO BRINGS IN $52.5 MILLION

Jan. 30, 1992

INITIATIVE PROPOSES 7% HIKE IN FUNDING

Jan. 30, 1992

BUSH BUDGET'S IMPACT ON BIOTECH

Jan. 30, 1992

ATHENA TOXIN DESIGNATED ORPHAN

Jan. 30, 1992

ANALYST PREDICTS FDA WILL APPROVE E5

Jan. 29, 1992

Growth Factor Antibody Prevents Scars

Jan. 29, 1992

COLLAGEN SALES CONTINUE TO LAG

Jan. 29, 1992

BUSH PROMISES $76 BILLION FOR TECHNOLOGY

Jan. 29, 1992

MATRIX IPO RAKES IN $52.5 MILLION

Jan. 29, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...